{"transactions":[{"id":734252,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-17T17:18:46.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":16800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16800,"derivative":{"exercise_price":1.5,"exercise_date":"2027-06-16","expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":16800},"source":{"system":"sec-edgar","filing":"0001424620-26-000002","document":"form4-06172026_050642.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000142462026000002/form4-06172026_050642.xml","form_type":"4"}},{"id":1097985,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-01T18:02:30.000Z","date":"2025-06-27","kind":"grant","planned":false,"acquired":true,"shares":2362,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2362,"derivative":{"exercise_price":4.71,"exercise_date":"2026-06-27","expiration_date":"2035-06-27","underlying":"Common Stock","underlying_shares":2362},"source":{"system":"sec-edgar","filing":"0001415889-25-018645","document":"form4-07012025_060727.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588925018645/form4-07012025_060727.xml","form_type":"4"}},{"id":1103913,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-23T15:59:08.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":210,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":420,"derivative":{"exercise_price":4.8,"exercise_date":"2026-06-18","expiration_date":"2035-06-18","underlying":"Common Stock","underlying_shares":210},"source":{"system":"sec-edgar","filing":"0001415889-25-017934","document":"form4-06232025_030604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588925017934/form4-06232025_030604.xml","form_type":"4"}},{"id":1103912,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-23T15:59:08.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":210,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":210,"derivative":{"exercise_price":4.8,"exercise_date":"2026-06-18","expiration_date":"2035-06-18","underlying":"Common Stock","underlying_shares":210},"source":{"system":"sec-edgar","filing":"0001415889-25-017934","document":"form4-06232025_030604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588925017934/form4-06232025_030604.xml","form_type":"4"}},{"id":1612523,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-28T18:09:44.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":4167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest 100% on February 26, 2025, one year following the grant date."}],"balance_after":4167,"derivative":{"exercise_price":0.357,"expiration_date":"2034-02-26","underlying":"Common Stock","underlying_shares":4167},"source":{"system":"sec-edgar","filing":"0001415889-24-005684","document":"form4-02282024_060238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588924005684/form4-02282024_060238.xml","form_type":"4"}},{"id":1849751,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-20T18:01:31.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest 100% on June 15, 2024, one year following the grant date."}],"balance_after":5250,"derivative":{"exercise_price":1.85,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":5250},"source":{"system":"sec-edgar","filing":"0001415889-23-009989","document":"form4-06202023_060625.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588923009989/form4-06202023_060625.xml","form_type":"4"}},{"id":2218776,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-30T18:01:46.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest 100% on June 23, 2023, one year following the grant date."}],"balance_after":5250,"derivative":{"exercise_price":4.23,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":5250},"source":{"system":"sec-edgar","filing":"0001415889-22-007087","document":"form4-06302022_110637.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588922007087/form4-06302022_110637.xml","form_type":"4"}},{"id":2422421,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Common Stock","published_at":"2022-01-28T21:29:28.000Z","date":"2021-02-23","kind":"gift","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":202477,"source":{"system":"sec-edgar","filing":"0001326110-22-000004","document":"wf-form5_164340534436499.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000132611022000004/wf-form5_164340534436499.xml","form_type":"5"}},{"id":2449896,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T20:19:57.000Z","date":"2022-01-04","kind":"purchase","acquired":true,"shares":1000,"price":5.65,"value":5650.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001415889-22-000165","document":"form4-01042022_120143.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588922000165/form4-01042022_120143.xml","form_type":"4"}},{"id":2657560,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-23T18:52:42.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":7875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 12 equal monthly installments following the grant date."}],"balance_after":7875,"derivative":{"exercise_price":6.5,"expiration_date":"2031-06-22","underlying":"Common Stock","underlying_shares":7875},"source":{"system":"sec-edgar","filing":"0001415889-21-003152","document":"form4-06232021_110629.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588921003152/form4-06232021_110629.xml","form_type":"4"}},{"id":2948555,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-11T21:20:10.000Z","date":"2020-12-10","kind":"sale","acquired":false,"shares":42592,"price":10.8265,"value":461122.288,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 42,592 shares sold in the price range of $10.17 to $11.14 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":207477,"source":{"system":"sec-edgar","filing":"0001209191-20-062936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919120062936/doc4.xml","form_type":"4"}},{"id":3049814,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-21T20:38:33.000Z","date":"2020-08-19","kind":"sale","acquired":false,"shares":20000,"price":9.19,"value":183800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales made in order to satisfy tax payments paid, accrued and/or owed by the reporting person."}],"balance_after":250069,"source":{"system":"sec-edgar","filing":"0001209191-20-047941","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919120047941/doc4.xml","form_type":"4"}},{"id":3058615,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T23:13:05.000Z","date":"2020-08-13","kind":"sale","acquired":false,"shares":20000,"price":9.34,"value":186800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales made in order to satisfy tax payments paid, accrued and/or owed by the reporting person."}],"balance_after":270069,"source":{"system":"sec-edgar","filing":"0001209191-20-046677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919120046677/doc4.xml","form_type":"4"}},{"id":3058614,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T23:13:05.000Z","date":"2020-08-13","kind":"sale","acquired":false,"shares":20000,"price":9.49,"value":189800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales made in order to satisfy tax payments paid, accrued and/or owed by the reporting person."}],"balance_after":290069,"source":{"system":"sec-edgar","filing":"0001209191-20-046677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919120046677/doc4.xml","form_type":"4"}},{"id":3058613,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T23:13:05.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":210,"price":10.55,"value":2215.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales made in order to satisfy tax payments paid, accrued and/or owed by the reporting person."}],"balance_after":310069,"source":{"system":"sec-edgar","filing":"0001209191-20-046677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919120046677/doc4.xml","form_type":"4"}},{"id":3058612,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T23:13:05.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":19790,"price":10.35,"value":204826.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales made in order to satisfy tax payments paid, accrued and/or owed by the reporting person."}],"balance_after":310279,"source":{"system":"sec-edgar","filing":"0001209191-20-046677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919120046677/doc4.xml","form_type":"4"}},{"id":3113272,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-11T22:25:06.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 10, 2021 or the date immediately preceding the 2021 annual meeting of stockholders."}],"balance_after":100000,"derivative":{"exercise_price":6.21,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-20-036040","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919120036040/doc4.xml","form_type":"4"}},{"id":3340835,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-17T00:40:47.000Z","date":"2019-12-16","kind":"sale","acquired":false,"shares":10000,"price":3.14,"value":31400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2019 by the reporting person."}],"balance_after":330069,"source":{"system":"sec-edgar","filing":"0001209191-19-060767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919119060767/doc4.xml","form_type":"4"}},{"id":3340834,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-17T00:40:47.000Z","date":"2019-12-13","kind":"sale","acquired":false,"shares":10000,"price":2.98,"value":29800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2019 by the reporting person."}],"balance_after":340069,"source":{"system":"sec-edgar","filing":"0001209191-19-060767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919119060767/doc4.xml","form_type":"4"}},{"id":3340833,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-17T00:40:47.000Z","date":"2019-12-13","kind":"sale","acquired":false,"shares":10000,"price":2.48,"value":24800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2019 by the reporting person."}],"balance_after":350069,"source":{"system":"sec-edgar","filing":"0001209191-19-060767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919119060767/doc4.xml","form_type":"4"}},{"id":3343580,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-12T23:29:39.000Z","date":"2019-12-12","kind":"sale","acquired":false,"shares":10000,"price":1.9918,"value":19918.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2019 by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 10,000 shares sold in the price range of $1.98 to $2.01 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":360069,"source":{"system":"sec-edgar","filing":"0001209191-19-060285","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919119060285/doc4.xml","form_type":"4"}},{"id":3419482,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-09T20:42:53.000Z","date":"2019-09-09","kind":"sale","acquired":false,"shares":13956,"price":1.24,"value":17305.44,"ownership":{"direct":true},"balance_after":370069,"source":{"system":"sec-edgar","filing":"0001209191-19-048906","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919119048906/doc4.xml","form_type":"4"}},{"id":3419481,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-09T20:42:53.000Z","date":"2019-09-06","kind":"sale","acquired":false,"shares":7080,"price":1.24,"value":8779.2,"ownership":{"direct":true},"balance_after":384025,"source":{"system":"sec-edgar","filing":"0001209191-19-048906","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919119048906/doc4.xml","form_type":"4"}},{"id":3419480,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-09T20:42:53.000Z","date":"2019-09-05","kind":"sale","acquired":false,"shares":2964,"price":1.25,"value":3705.0,"ownership":{"direct":true},"balance_after":391105,"source":{"system":"sec-edgar","filing":"0001209191-19-048906","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919119048906/doc4.xml","form_type":"4"}},{"id":3497054,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-07T20:47:19.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":92592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of NantKwest, Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award will vest on the earlier to occur of June 6, 2020 or the date immediately preceding the 2020 annual meeting of stockholders."}],"balance_after":394069,"source":{"system":"sec-edgar","filing":"0001209191-19-035606","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919119035606/doc4.xml","form_type":"4"}},{"id":3846599,"issuer":{"id":152369,"kind":"organization","name":"NOVELION THERAPEUTICS INC.","symbol":"NVLNF"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-13T16:30:34.000Z","date":"2018-08-09","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each option has an exercise price equal to the closing price of a common share of the Issuer on the Nasdaq Global Select Market on the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in twelve equal monthly installments, beginning one month after the grant date."}],"balance_after":10000,"derivative":{"exercise_price":3.33,"expiration_date":"2028-08-09","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-18-051499","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/827809/000110465918051499/a4.xml","form_type":"4"}},{"id":3898330,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-11T20:17:24.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":27322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of NantKwest, Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award will vest on the earlier to occur of June 7, 2019 or the date immediately preceding the 2019 annual meeting of stockholders."}],"balance_after":301477,"source":{"system":"sec-edgar","filing":"0001209191-18-036927","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919118036927/doc4.xml","form_type":"4"}},{"id":4111443,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-03T21:20:06.000Z","date":"2018-01-02","kind":"gift","acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":274155,"source":{"system":"sec-edgar","filing":"0001209191-18-000869","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919118000869/doc4.xml","form_type":"4"}},{"id":4124929,"issuer":{"id":95079,"kind":"organization","name":"Innoveren Scientific, Inc.","symbol":"IVRN"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-20T12:41:18.000Z","date":"2017-12-15","kind":"purchase","acquired":true,"shares":6000,"price":0.7,"value":4200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares purchased trade publicly under the symbol \"MDVX\" on the OTCQB Tier of the OTC Markets, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares purchased trade publicly under the symbol \"MDVX\" on the OTCQB Tier of the OTC Markets, Inc."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4/A is being filed solely to correct a typographical error in Item 4, which reported the transaction as a disposition instead of an acquisition."}],"balance_after":115960,"source":{"system":"sec-edgar","filing":"0001493152-17-014832","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000149315217014832/form4a.xml","form_type":"4/A","original_submission_date":"2017-12-19"}},{"id":4126278,"issuer":{"id":95079,"kind":"organization","name":"Innoveren Scientific, Inc.","symbol":"IVRN"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-19T21:30:54.000Z","date":"2017-12-15","kind":"purchase","acquired":false,"shares":6000,"price":0.7,"value":4200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares purchased trade publicly under the symbol \"MDVX\" on the OTCQB Tier of the OTC Markets, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares purchased trade publicly under the symbol \"MDVX\" on the OTCQB Tier of the OTC Markets, Inc."}],"balance_after":115960,"source":{"system":"sec-edgar","filing":"0001493152-17-014767","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000149315217014767/form4.xml","form_type":"4"}},{"id":4176327,"issuer":{"id":95079,"kind":"organization","name":"Innoveren Scientific, Inc.","symbol":"IVRN"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-01T22:30:57.000Z","date":"2017-10-30","kind":"grant","acquired":true,"shares":12821,"price":1.17,"value":15000.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 12,821 shares of common stock in lieu of cash fees that were due to the Reporting Person as of September 30, 2017 for his board services. The number of shares issued is based on the accrued but unpaid director fees owed to the Reporting Person during the nine months ended 2017, divided by the average closing price of the Issuer's common stock during the nine months ended 2017."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted 12,821 shares of common stock in lieu of cash fees that were due to the Reporting Person as of September 30, 2017 for his board services. The number of shares issued is based on the accrued but unpaid director fees owed to the Reporting Person during the nine months ended 2017, divided by the average closing price of the Issuer's common stock during the nine months ended 2017."}],"balance_after":109960,"source":{"system":"sec-edgar","filing":"0001493152-17-012285","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000149315217012285/form4.xml","form_type":"4"}},{"id":4275219,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-21T20:03:23.000Z","date":"2017-06-20","kind":"sale","acquired":false,"shares":10000,"price":7.54,"value":75400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2016."}],"balance_after":278655,"source":{"system":"sec-edgar","filing":"0001209191-17-041195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919117041195/doc4.xml","form_type":"4"}},{"id":4275218,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-21T20:03:23.000Z","date":"2017-06-20","kind":"sale","acquired":false,"shares":20000,"price":7.44,"value":148800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2016."}],"balance_after":288655,"source":{"system":"sec-edgar","filing":"0001209191-17-041195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919117041195/doc4.xml","form_type":"4"}},{"id":4275217,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-21T20:03:23.000Z","date":"2017-06-20","kind":"sale","acquired":false,"shares":10000,"price":7.43,"value":74300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2016."}],"balance_after":308655,"source":{"system":"sec-edgar","filing":"0001209191-17-041195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919117041195/doc4.xml","form_type":"4"}},{"id":4283588,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-13T20:13:57.000Z","date":"2017-06-09","kind":"grant","acquired":true,"shares":23753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of NantKwest, Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the one year anniversary of the vesting commencement date on the same day of the month as the vesting commencement date. The vesting commencement date for this award is June 9, 2017."}],"balance_after":318655,"source":{"system":"sec-edgar","filing":"0001209191-17-039436","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919117039436/doc4.xml","form_type":"4"}},{"id":4298021,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-01T20:29:54.000Z","date":"2017-05-30","kind":"gift","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":294902,"source":{"system":"sec-edgar","filing":"0001209191-17-036789","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919117036789/doc4.xml","form_type":"4"}},{"id":4457101,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-11T00:24:45.000Z","date":"2016-08-29","kind":"gift","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":307402,"source":{"system":"sec-edgar","filing":"0001209191-17-009780","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919117009780/doc5.xml","form_type":"5"}},{"id":4489843,"issuer":{"id":95079,"kind":"organization","name":"Innoveren Scientific, Inc.","symbol":"IVRN"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-17T17:19:19.000Z","date":"2017-01-12","kind":"grant","acquired":true,"shares":21739,"price":1.38,"value":29999.82,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted 21,739 shares of common stock in lieu of cash fees that were due to the Reporting Person as of December 31, 2016 for his board services during fiscal years 2015 and 2016.  The number of shares issued is based on the accrued but unpaid director fees owed to the Reporting Person during fiscal years 2015 and 2016, divided by average closing price of the Issuer's common stock during fiscal year 2016."}],"balance_after":97139,"source":{"system":"sec-edgar","filing":"0001415889-17-000100","document":"form4-01172017_090109.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000141588917000100/form4-01172017_090109.xml","form_type":"4"}},{"id":4512141,"issuer":{"id":152369,"kind":"organization","name":"NOVELION THERAPEUTICS INC.","symbol":"NVLNF"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-27T16:13:02.000Z","date":"2016-12-22","kind":"grant","acquired":true,"shares":9600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each option has an exercise price equal to the closing price of a common share of the Issuer on the Nasdaq Global Select Market on the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The common shares underlying this stock option award will vest in equal monthly installments over 36 months, beginning one month after the grant date."}],"balance_after":9600,"derivative":{"exercise_price":8.65,"expiration_date":"2026-12-22","underlying":"Common Shares","underlying_shares":9600},"source":{"system":"sec-edgar","filing":"0001104659-16-163888","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/827809/000110465916163888/a4.xml","form_type":"4"}},{"id":4535181,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-03T02:04:02.000Z","date":"2016-11-23","kind":"sale","acquired":false,"shares":7719,"price":7.5,"value":57892.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is filed to include 719 shares sold by the reporting person on November 23, 2016.  These 719 shares were incorrectly included in the amount of shares beneficially owned by the reporting person in a subsequent Form 4 filed November 29, 2016."}],"balance_after":315070,"source":{"system":"sec-edgar","filing":"0001209191-16-153188","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919116153188/doc4a.xml","form_type":"4/A","original_submission_date":"2016-11-23"}},{"id":4540095,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-29T22:42:44.000Z","date":"2016-11-25","kind":"sale","acquired":false,"shares":6168,"price":7.5,"value":46260.0,"ownership":{"direct":true},"balance_after":309621,"source":{"system":"sec-edgar","filing":"0001209191-16-152339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919116152339/doc4.xml","form_type":"4"}},{"id":4542997,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-23T21:26:54.000Z","date":"2016-11-23","kind":"sale","acquired":false,"shares":7000,"price":7.5,"value":52500.0,"ownership":{"direct":true},"balance_after":315789,"source":{"system":"sec-edgar","filing":"0001209191-16-151970","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919116151970/doc4.xml","form_type":"4"}},{"id":4542996,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":37293,"kind":"person","name":"Thomas John C","position":1,"cik":"0001424620","reported_name":"Thomas John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-23T21:26:54.000Z","date":"2016-11-22","kind":"sale","acquired":false,"shares":13000,"price":7.5,"value":97500.0,"ownership":{"direct":true},"balance_after":322789,"source":{"system":"sec-edgar","filing":"0001209191-16-151970","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424620/000120919116151970/doc4.xml","form_type":"4"}}]}